What is the recommended dose of domperidone (antiemetic medication) for a 5-year-old child weighing 14.9kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Domperidone Dosing for a 5-Year-Old Child Weighing 14.9kg

The recommended dose of domperidone for a 5-year-old child weighing 14.9kg is 0.2-0.4 mg/kg/dose given 3-4 times daily, which calculates to approximately 3-6 mg per dose.

Dosing Calculation

For pediatric patients, domperidone dosing should be weight-based:

  • Standard pediatric dosing range: 0.2-0.4 mg/kg/dose
  • For a 14.9kg child:
    • Minimum dose: 14.9kg × 0.2 mg/kg = 2.98 mg (round to 3 mg)
    • Maximum dose: 14.9kg × 0.4 mg/kg = 5.96 mg (round to 6 mg)
  • Frequency: 3-4 times daily before meals and at bedtime

Important Safety Considerations

Cardiac Risk

Domperidone has been associated with QT interval prolongation and increased risk of sudden cardiac death, particularly at doses ≥30 mg/day in adults 1, 2. Therefore:

  • Always use the lowest effective dose
  • Consider baseline ECG to assess QTc interval before initiating therapy
  • Avoid in patients with:
    • Pre-existing cardiac conditions
    • Family history of cardiac arrhythmias
    • Concomitant medications that prolong QT interval

Administration Guidelines

  • Give 15-30 minutes before meals and at bedtime
  • Oral suspension is preferred for accurate dosing in children
  • Duration of treatment should be limited to the shortest period necessary for symptom control

Clinical Indications

Domperidone is used as:

  • An antiemetic for nausea and vomiting
  • A prokinetic agent for upper gastrointestinal motility disorders 3, 4

Monitoring

  • Monitor for extrapyramidal side effects, although these are less common with domperidone than with metoclopramide due to minimal blood-brain barrier penetration 4
  • Watch for gastrointestinal side effects (abdominal cramps, diarrhea)
  • If treatment extends beyond short-term use, consider periodic cardiac evaluation

Advantages Over Other Antiemetics

Domperidone has minimal central nervous system penetration compared to metoclopramide, resulting in fewer neurological side effects 3, 4. This makes it potentially safer for pediatric use when an antiemetic is necessary.

Limitations

Despite its use in many countries, domperidone is not FDA-approved in the United States due to safety concerns 5. Its use should be carefully considered, especially in pediatric populations where long-term safety data are limited.

References

Research

Domperidone and sudden death.

Prescrire international, 2006

Research

Domperidone, a new dopamine antagonist.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1986

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.